Several groundbreaking therapies are now accessible in the United Kingdom for treating glucose intolerance. Saxenda, Metformin, and Mounjaro represent unique approaches, with Wegovy and Mounjaro being injectable GLP-1 receptor agonists primarily aimed at fat reduction alongside blood sugar contro